INTRODUCTION
Microscopic examination of rheumatoid synovial tissue reveals a chronic inflammatory infiltrate consisting primarily of lymphocytes, plasma cells, and macrophages. Immunofluorescent studies (2, 3) have shown that many of these infiltrating cells contain the immunoglobulins IgG and IgM as well as rheumatoid factor. The local synthesis of these immunoglobulins within the rheumatoid synovium has been demonstrated by an in vitro culture technique and the proportion of newly synthesized protein representing av-globulin has been shown to be similar to that produced by normal human spleen and lymph nodes (4) . The antigenic specificity of the im-niunoglobulin produced by the rheumatoid synovium is unknown. It could have antibody characteristics reflecting the general immune status of the patient, or it could represent specific antibody directed against antigens localized within the inflamed joint. To distinguish between these two possibilities, a comparison has been made of the immunoglobulin and specific antibody synthesized in vitro by rheumatoid synovial tissue with that produced simultaneously by peripheral blood lymphocytes (PBL) obtained from patients immunized with tetanus toxoid.
In recent experiments performed in this laboratory (5), a nonspecific synovitis was produced by streptolysin S in rabbits undergoing a secondary response to bovine serum albumin (BSA) and the synthesis of specific antibody by the synovial membrane measured in vitro. The percentage of 'v-globulin representing specific antibody formed by the synovium of these rabbits was similar to that produced by PBL cultured simultaneously. However, in the present investigation, the rheumatoid synovium was found to be markedly limited in its response to tetanus antigen in comparison with the PBL.
METHODS
Patients. Synovial tissues and peripheral blood specimens were obtained from 16 adult patients with classical rheumatoid arthritis (RA) as defined by the criteria of the American Rheumatism Association (6) and from three otherwise normal patients undergoing knee cartilage revision procedures. In addition, the synovium from the knee of a patient with acute Reiter's syndrome was obtained by repeated needle punch biopsies 6 days after immunization, and cultured in a similar manner. Sequential PBL cultures derived from three normal individuals were also studied.
Tetanus immunization. To determine the optimal time prior to synovectomy for immunization of patients with RA, sequential bleedings of 50 ml were obtained from three normal subjects at the time intervals indicated in Fig. 1 following secondary immunization with 0.5 ml of alum phosphate adsorbed tetanus toxoid (Parke, Davis & Co., Detroit, Mich.). The same volume of tetanus toxoid was injected intramuscularly in 14 patients with RA at 2-to 14-day intervals prior to synovectomy. The nonrheumatoid patients were immunized 6 days before surgery; three of the rheumatoid patients had received one, and three others, two tetanus toxoid injections during the 6 months prior to the immunization given before synovectomy. In the remaining eight patients, whether or not previous tetanus immunization had occurred could not be determined. 2 of the 14 patients, L. C. and M. M., were given an intraarticular injection of one-one thousandth and one-five hundredth of the challenging antigen dose into a metacarpophalangeal (MCP) and a knee joint, respectively, in addition to the usual 0.5 ml of tetanus toxoid intramuscularly prior to synovectomy. In the case of L. C., one injected MCP and four noninjected MCP joints were operated upon, thus permitting a comparison of the response to direct intra-articular antigenic stimulation with the response elicited by antigen given systemically. Synovial and PBL cultures from two patients who were not immunized prior to surgery were also studied.
Tissue incubation. Synovial tissue was cultured as described previously (4), with the following modifications. To each gram of minced synovial membrane, there were added 3 ml of Eagle's medium (7) lacking arginine, leucine, lysine, valine, and serum, but supplemented with 25 ,ug of hydrocortisone per ml and 3 ,gCi of an amino acid-`4C labeling mixture (Schwarz BioResearch, Orangeburg, N. Y.) containing arginine-14C (166 mCi/mmole), leucine (103 mCi/mmole), lysine (100 mCi/mmole), and valine (80 mCi/mmole).
Peripheral blood lymphocyte incubation. Venous blood, heparinized and diluted by an additional one-third volume of 6% dextran (mol wt 200,000) in saline, was permitted to sediment for 1.5 hr at 37°C. The leukocyte-rich supernatant was sampled for a cell count, then centrifuged at 150 g for 10 min at 4°C. The unwashed cell pellet was resuspended in medium to a final concentration of 10 X 106 cells per ml and 1 uCi of the amino acid-14C labeling mixture added per ml.
The incubation was conducted in a bubble tube in the same manner as that of the synovial suspension (4) .
Processing of culture suspernatants. At the end of the 6-hr incubation period, the cell or tissue suspension was frozen, thawed once, and spun at 105,000 g for 1 hr in a Spinco Model L ultracentrifuge at 4°C. The supernatants were divided into two equal portions which were processed as diagrammed in Fig. 2 Preparation of antisera. Specific goat antisera to IgG and IgA, and rabbit antiserum to IgM were prepared as previously described (4) . Human anti-tetanus antibody was secured from a normal subject following two injections of 0.5 ml of tetanus toxoid or purchased from The Cutter Laboratories, Berkeley, Calif. This antiserum, when permitted to react with a nonalum-adsorbed tetanus toxoid preparation, kindly furnished by the Research Division of Parke, Davis & Co. Laboratories, Detroit, Mich., produced a single precipitin line by Ouchterlony analysis (9).
Immunoglobulin and specific antibody determinations. Before specific precipitation of antibody-'4C, all supernatant fractions were subjected to two prior immune precipitations with BSA: anti-BSA at equivalence in order to remove nonspecific radioactivity (10) . The appropriate nonradioactive immunoglobulin (IgA, IgG, or IgM) and specific antisera were added at slight antibody excess to aliquots of the above supernatant to obtain 2 mg of antigen-antibody precipitate. After incubation at 37°C for 1 hr, then overnight at 4°C, each tube was centrifuged at 17,000 rpm in a Sorvall SS-1 centrifuge (Ivan Sorvall, Inc., Norwalk, Conn.). The supernatant was checked by capillary precipitation with additional antibody to demonstrate that complete precipitation had occurred. The immune precipitates were then washed and radioactivity determined as described previously (4) . Tetanus: anti-tetanus precipitations were performed in a similar manner. Protein-bound radioactivity was determined by precipitation with 10% trichloroacetic acid. Radioimmunoelectrophoresis. Samples of concentrated culture supernatant, to which a small amount of normal human serum containing tetanus antibody as carrier had been added, were subjected to immunoelectrophoresis in agar (11) and developed against anti-whole human serum in one trough and against tetanus antigen in the other. Following repeated washing, slides were dried and exposed to Polaroid Land Film, Type 57, ASA 3000, for 5 wk before development.
RESULTS Tetanus antibody response in PBL. In three normal subjects challenged with tetanus toxoid, the following evidence indicated that the tetanus antibody was present predominantly in the IgG fraction. Precipitation of nonfractionated supernatants of PBL incubations with antihuman IgG followed by anti-tetanus: tetanus precipitation showed that all 14C-labeled tetanus antibody had been removed by the anti-IgG; testing of the sucrose density gradient fractions of the supernatants which contained IgM failed to demonstrate '4C-labeled tetanus antibody; and radioimmunoelectrophoresis of the supernatant solutions produced a radioactive precipitin line with tetanus antigen in the slowly moving IgG region, but not in the areas occupied by IgA or IgM. Tetanus antibody-'4C determinations on DEIAE peak I fractions gave similar results to those shown in Fig. 1 (Table II) . The Reiter's patient's PBL was not cultured. The synovia and PBL of three otherwise normal patients undergoing knee cartilage revision procedures following trauma were also studied. Two of the three showed tetanus antibody production by peripheral blood lymphocytes, but none of the three synovia produced detectable tetanus antibody. The amount of IgG produced by these synovia was very small: an av- (Table II) . However, only negligible amounts (0.0 and 0.3%, respectively) of the IgG-14C synthesized by the synovial tissue obtained from the injected joints represented specific antibody. In L. C., only 0.66% of the IgG-1'C produced by the noninjected metacarpophalangeal synovial tissue was measured as "specific" tetanus antibody, about the same as that from the synovial cultures from the two nonchallenged patients who produced 0.4 and 0.5%, respectively (Table I ). It is apparent that no increase in specific antibody synthesis resulted from intra-articular injection of tetanus antigen.
DISCUSSION
Although cells comprising the chronic inflammatory infiltrate of the rheumatoid synovial membrane synthesize a significant proportion of their soluble protein as immunoglobulin (4), the antibody specificity of this y-globulin relative to the over-all immune status of the patient is unknown. The administration of a secondary antigenic challenge with tetanus toxoid at varying times prior to synovectomy has permitted evaluation of the amount of specific antibody synthesized by the rheumatoid synovium, and comparison of this response with that of the PBL which were shown to be responding actively at the time of surgery.
When two distinctively different tissues such as synovium and PBL are compared in their ability to incorporate 14C-labeled amino acids, the data derived do not indicate an absolute level of protein or specific antibody synthesis. The pool size of the amino acids used for labeling may well be different in the two culture systems, resulting in different specific radioactivities for the incorporated amino acids. This would cause variation in the amount of label incorporated into similar quantities of newly synthesized protein. However, a comparison of the relative proportion of total protein synthesis within each tissue representing immunoglobulin or specific antibody would seem justifiable since the specific radioactivity of newly synthesized total protein and antibody may be assumed to vary in parallel within a given culture.
The present study (Fig. 1) is the first to establish the time of maximum antibody synthesis by PBL in the anamnestic response in man. It has demonstrated a clearly defined period of specific antibody synthesis with an optimum on the 5th day. However, the choice of the best time for study of an immune response by synovial tissue to permit a meaningful comparison with the response of PBL was less obvious. The period from 2.5 to 6 days following injection of antigen was chosen for the following reasons. The secondary immune response of man is similar to that of the rabbit in that maximum Not only did the synovium fail to synthesize tetanus antibody at the time when the PBL were producing considerable amounts of this antibody, but it also failed to do so immediately prior to this time period and subsequently to it when antibody synthesis was not occurring in the PBL. The ratio of ay-globulin synthesized to TCAprecipitable protein synthesized has been found to be similar in RA synovium to that of human spleen and lymph nodes (4) . Since in studies cited above (14) , lymph nodes demonstrated maximum antibody synthesis by the 3rd day after antigenic challenge, this time period was carefully evaluated in the present study. When 2.5 and 3 days were allowed between injection of tetanus antigen and synovectomy, negligible antibody was formed in both PBL and synovial tissue cultures. Similar results were observed in the PBL and synovial cultures from the patient studied 14 days after tetanus injection.
At least two possibilities could account for the deficient synovial response to tetanus antigen. The lymphocytes of the synovium may not exchange freely with the recirculating lymphocyte pool (16) Loewi (17) has also studied experimental immune inflammation in the synovial membrane. He found that immunized guinea pigs, when injected with specific antigen intra-articularly, rsponded with a chronic mononuclear inflammatory reaction, suggesting that active immunization within the joint was required for persistence of the local synovitis. If local penetration of the joint by antigen were necessary to activate antibody synthesis, and this did not occur in adequate amount following the usual intramuscular injection of the antigen, it would be possible to explain the lack of specific antibody synthesis which was observed. For this reason, in two patients, the challenging dose was supplemented with a small amount of antigen administered intra-articularly 4 and 5 days before surgery. In one of these, L. C., a number of joints were subjected to synovectomy, permitting a comparison of the effect of intra-articular injections of antigen with that of systemic immunization alone (Table II) . Essentially no tetanus antibody was formed by any of these synovial cultures, although the PBL of both patients produced specific antibody. Thus, even intra-articularly administered antigen did not stimulate synovial antibody synthesis in systemically immunized patients. Since synovial membrane did not synthesize antibody either before, during, or after the time when the PBL were synthesizing such antibody, and since the synovium of immunized patients did not respond to locally injected antigen, it would appear likely that the v-globulin synthesized in rheumatoid synovitis represents a commitment to some other antigen. It is possible that such an antigen might be localized to the joint. The recent studies of experimental pyelonephritis produced by E. coli by Lehmann, Smith, Miller, Barnett, and Sanford (18) provide an excellent example of such local synthesis of antibody to a known antigen by a chronic lymphoid infiltrate similar to that found in the rheumatoid synovium.
Unfortunately, synovectomy is rarely performed in patients with inflammatory arthritis other than rheumatoid arthritis. In the four synovial cultures from nonrheumatoid patients presented in Table III , only one from a patient with Reiter's syndrome could be considered truly comparable with rheumatoid synovial tissue. It is of interest that this Reiter's tissue also showed a low percentage (3.3%) of the IgG produced in culture to be anti-tetanus antibody. It is interesting, although of questionable significance, that this was a higher percentage of IgG representing antibody than any of the rheumatoid synovia studied (average 0.8%).
Although the PBL cultured from 10 of the patients were secured at an optimum time for antibody synthesis, the amounts of newly synthesized IgG and tetanus antibody measured were only 30-40% of that observed in the three normal control subjects. However, the small number of the normal subjects studied and the difference in age of the two groups does not permit a conclusion relative to this apparent difference.
